Isolated, isovolumic rat hearts, perfused by Krebs-Henseleit buffer at constant coronary flow rate, were used to explore the hypothesis that endogenous cardiac glutathione provides protection against myocardial dysfunction associated with short periods of ischemia. Experimental animals were depleted of cardiac glutathione to 35% of control levels by intraperitoneal injections of diethylmaleate (DEM). Left ventricular pressure, coronary perfusion pressure, and glutathione levels were measured in control and experimental hearts after 60 minutes of oxygenated perfusion and after 20 minutes of global, no-flow ischemia and 30 minutes of reperfusion. With each protocol, both control and glutathione-depleted hearts received either standard buffer or one supplemented with 2 mM glutathione. Recovery of systolic function after ischemia-reperfusion was impaired in DEM-treated hearts compared with controls. In addition, the rise in perfusion pressure and chamber stiffness was also greater in DEM-treated hearts compared with controls. Recovery in glutathione-depleted hearts was improved when the reperfusate was supplemented with glutathione. In addition, the supplemented reperfusate prevented the decrease in compliance and the increase in coronary perfusion pressure in the glutathione-depleted hearts. Ischemia-reperfusion alone were not associated with a significant alteration in myocardial glutathione levels. Prewashout myocardial levels of glutathione were elevated after reperfusion with glutathione-supplemented bulfer but fell to baseline levels after a short washout period. These studies demonstrate that endogenous glutathione is important in protection of myocardium from injury after ischemia-reperfusion, presumably by modifying levels of active oxygen intermediates. The smaller changes in left ventricular pressure and coronary resistance after administration of GSH probably reflects an extracellular mechanism because benefit is seen soon after reperfusion. (Circulation 1989;80:1449-1457 D uring oxidative metabolism, cells produce potentially toxic oxygen radicals for which both specific and nonspecific scavenging mechanisms are present. Recently, it has been suggested that hypoxia or ischemia, followed by reoxygenation or reperfusion, increases production of oxygen radical species.1-5Administration of exogenous quenchers of free radicals, such as superoxide dismutase (SOD), catalase or both, improve cardiac function and limit infarct size when administered after experimental global ischemia.6,7 Glutathione, an endogenous sulfhydryl-containing peptide, prevents free radical formation and accompanying tissue injury by acting as a substrate for glutathione peroxidase during the reduction of hydrogen peroxide and organic peroxides. Oxidized glutathione is then either reduced via a glutathione reductase-catalyzed reaction with NADPH or transported out of the cell. Export of oxidized glutathione (glutathione disulfide [GSSG]) by cells or perfused organ systems has been used as an indicator of oxidant stress.8 9 Because protection against oxidant injury from various sources correlates with levels of glutathione, glutathione peroxidase, and glutathione reductase in many noncardiac tissues, we reasoned that glutathione might be important in the heart as well. In support of this hypothesis is the finding that glutathione-depleted hearts exhibit evidence of increased lipid peroxidation during oxygenated perfusion.10 Short periods of myocardial ischemia or hypoxia are associated with reversibly depressed systolic performance upon restoration of flow or oxygen
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Glutathione, an endogenous sulfhydryl-containing peptide, prevents free radical formation and accompanying tissue injury by acting as a substrate for glutathione peroxidase during the reduction of hydrogen peroxide and organic peroxides. Oxidized glutathione is then either reduced via a glutathione reductase-catalyzed reaction with NADPH or transported out of the cell. Export of oxidized glutathione (glutathione disulfide [GSSG] ) by cells or perfused organ systems has been used as an indicator of oxidant stress.8 9 Because protection against oxidant injury from various sources correlates with levels of glutathione, glutathione peroxidase, and glutathione reductase in many noncardiac tissues, we reasoned that glutathione might be important in the heart as well. In support of this hypothesis is the finding that glutathione-depleted hearts exhibit evidence of increased lipid peroxidation during oxygenated perfusion.10 Short periods of myocardial ischemia or hypoxia are associated with reversibly depressed systolic performance upon restoration of flow or oxygen (".stunned" myocardium). Recovery of the stunned myocardium may be delayed for hours or Standard Versus Supplemented Reperfusate A separate group of hearts from DEM-treated animals and their controls was subjected to 60 minutes of oxygenated perfusion with either modified Krebs-Henseleit buffer or buffer supplemented with 2 mM reduced glutathione or to 50 minutes of glutathione-supplemented buffer followed by 10 minutes of washout with standard buffer. Ventricular function curves, no flow curves, and coronary artery perfusion pressure were recorded at the end of the 60-minute perfusion period.
At the termination of the experiment and while still being perfused, hearts for biochemical analysis were incised from apex to base, frozen in less than 10 seconds with a clamp prechilled in liquid nitrogen, and stored at -70°C. Other hearts were used for dry weight determinations. After removal from the apparatus, the ventricle of these hearts was opened to ensure proper placement of the balloon, and the atria and great vessels were carefully trimmed. These hearts were weighed, placed in an oven at 370 C, and dried for 24 hours before obtaining a dry weight.
Measurement of Total Glutathione and Related Enzymes
Frozen heart samples were homogenized for 2 minutes in 0.005 M phosphate buffer (pH 7.8) using an Omnimixer. An aliquot of the homogenate for glutathione determination was treated with 1:10 vol ice-cold 1% perchloric acid. Both the aliquot and the remaining homogenate were centrifuged at 300g for 10 minutes, and the supernatant was frozen at -70°C. On thawing, the aliquot was then neutralized with a solution of 2 M KOH containing 0.3 M Nmorpholinopropanesulfonic acid buffer, and the resulting precipitate removed by centrifugation. The total tissue glutathione was determined using a modification of the method of Tietze The principal hypothesis to be tested was that in vivo administration of DEM under the conditions specified would reduce total cardiac glutathione and impair recovery of left ventricular function after ischemia and reperfusion. Therefore, the null hypothesis (i.e., that there was no effect of treatment) would be rejected if the change in left ventricular developed pressure after ischemia was equal to or greater in DEM-treated than control hearts. A secondary hypothesis, namely, that reintroduction of glutathione would restore tolerance to ischemia, was also tested. To determine this, equilibrium values of the desired variables were compared with values at end perfusion by a two-tailed paired t test. Data were also analyzed by assessing percentage differences between equilibrium and end-perfusion values in control and treated hearts and comparing the percentage differences by two-tailed unpaired t test. Differences were considered statistically significant at a p value of less than 0.05. Values are given in the tables as mean±SD. Results 
Cardiac Glutathione Levels
Total cardiac glutathione was measured at intervals after the administration of diethylmaleate (DEM; Table  1 ). Levels declined from a baseline of 1.77±0.47 to 0.78±0.25* reducing equiv/heart at 1.5 hours and 0.54±0.19* equiv/heart at 2 hours after DEM injection. The 1.5-and 2-hour post-DEM injection values were both reduced from baseline (*p<0.001 versus baseline) but were not statistically different from each other. Levels after 20 minutes of Krebs perfusion were also measured. In control hearts, total glutathione was 1.68±0.38 equiv/heart compared with 0.43±0.24 equiv/heart in DEM-treated hearts. Nei- However, ratios were significantly higher in perfused hearts than in those from freshly killed controls (p <0.001 oxygenated or ischemia-reperfusion versus respective control). Discussion
Our present study supports the hypothesis that endogenous glutathione has an important role in providing protection against myocardial injury after a short period of ischemia. Two lines of evidence favor this conclusion. The first is that lowering endogenous glutathione levels (without altering levels of glutathione peroxidase) impaired recovery of systolic function and increased coronary resistance and chamber stiffness. Such changes were observed only after ischemia and not with oxygenated perfusion. Second, the addition of glutathione into the reperfusate improved these same measurements of function in both control and glutathione-depleted hearts. Glutathione was added only to the reperfusate, identifying its primary contribution as coinciding with reperfusion, a time when oxygen radicals have been measured.3-5 Our studies do not allow us to exclude a direct effect of DEM, but we believe our results are explained by changes in glutathione.
Our data also suggest that glutathione may be particularly important in protecting the coronary vasculature. After ischemia, coronary perfusion pressure increased the most in glutathione-depleted hearts. This indicates a substantial rise in coronary resistance. Increased resistance can be due to external compression of intramyocardial vessels by interstitial pressure, a reduction in vascular crosssectional area due to endothelial injury, or an alteration in vasodilating capacity. There was no difference in water content between control and glutathione-depleted hearts after ischemia, which argues against an important contribution of external compression.
The most likely explanation for the increase in coronary resistance in the glutathione-depleted hearts after ischemia-reperfusion is endothelial injury. Endothelial cells are susceptible to oxidant, particularly peroxide-induced, injury. Harlan and colleagues demonstrated that glutathione depletion or inhibition of glutathione reductase greatly enhanced endothelial cell lysis due to hydrogen peroxide or activated leukocytes. 21 These data have been extended to show that oxidant stress activates the hexose monophosphate shunt and glutathione oxidation.22 Catalase has also been observed to be an important endogenous defense against peroxideinduced injury to endothelial cells.23 In wellperfused oxygenated rabbit septae exposed to superoxide radicals and peroxide generating systems, endothelial cells showed blebs and microprojections as well as vacuolization, changes similar to these seen after 1 hour of ischemia and reperfusion in the same preparation. Superoxide dismutase administered before the radical generating systems or during reperfusion largely prevented the ultrastructural changes. 24 The lower glutathione levels in our DEM-treated hearts may have reduced the capacity of endothelial cells to modulate levels of peroxide arising from the superoxide radicals generated during reperfusion. Either the peroxide itself or hydroxyl radicals formed from the peroxide might cause cell injury and swelling, leading to increased coronary vascular resistance. Alternatively, the active oxygen species may inactivate available mechanisms for generating endotheliumderived relaxing factor or the factor itself. 25 The largest increase in K was also observed after ischemia-reperfusion in glutathione-depleted hearts.
The increased stiffness could be attributed to an increase in coronary turgor because no increase in stiffness was observed in the absence of coronary flow. Many investigators have verified measurable effects of vascular turgor on passive chamber properties. Olsen and colleagues concluded that pressure, not flow, was the major contributor to shifts in compliance at varying perfusion pressures. 26 Vogel and associates measured compliance after ischemia and hypoxia15 and found evidence of an erectile effect at higher ventricular volumes, similar to that observed in our studies. We believe it is likely that injury within the coronary circulation increased perfusion pressure, which in turn led to decreased chamber compliance.
The use of a buffer perfused model allows precise control of hemodynamic variables and eliminates effects due to cellular blood elements, serum-borne factors, or neurohumoral influence. However, it does not permit a prolonged period of observation after reperfusion. In addition, the edema formation and high coronary flow rates in buffer-perfused preparations may amplify the effects of coronary turgor.
Impaired recovery of systolic function after ischemia-reperfusion in glutathione-depleted hearts could reflect either vascular changes or direct effects on myocytes. For example, a reduction in effective nutrient myocardial flow might have resulted in a period of prolonged myocardial ischemia after reflow, although Chatham and colleagues did not find an altered profile of high-energy phosphates in hearts depleted of glutathione using an inhibitor of glutathione synthesis. 27 The direct correlation between glutathione levels and cardiac function in our studies is best explained by the observed relation between oxygen radical formation and tissue injury. Several studies of stunned myocardium have implicated oxygen radicals as important mediators of reversible injury resulting in prolonged systolic dysfunction. Myers 34 One of glutathione's functions is to serve as part of an endogenous system that controls intracellular levels of hydrogen peroxide. The other components of the system are NADPH, the hexose monophosphate shunt, and the enzymes glutathione peroxidase and reductase. On exposure to peroxide, glutathione is oxidized; through the action of glutathione peroxidase, water and oxygen are formed. To maintain this system intact, the oxidized form of glutathione must be reduced, a process requiring NADPH and glutathione reductase. NADPH is, in turn, regenerated when glucose-6-phosphate is converted to 6-phosphogluconate and then to ribulose-5-phosphate.8 By depleting glutathione and restricting glucose available to the hexose monophosphate shunt during ischemia, conditions favoring accumulation of peroxide could be established. Peroxide, in turn, might interfere with ATP synthesis via glycolytic or mitochondrial pathways and impair function in reperfused myocardium. 35 Glutathione redox cycling is important in maintaining normal mitochondrial function. Mitochondria from ischemic myocardium have impaired carnitine-acylcarnitine translocase activity, a reduced matrix level of glutathione and evidence of marked glutathione oxidation. When ischemic mitochondria were incubated with glutathione, translocase activity promptly increased toward control values and decreased presumptive evidence for lipid peroxidation.36 More recent experiments in isolated buffer perfused hearts subjected to 60 minutes of ischemia, a time when myocardial GSH levels have decreased, indicate that pretreatment with N-acetylcysteine increases cardiac glutathione. After reperfusion, there was less contracture, improved systolic performance, and better recovery of mitochondrial function.37 Depletion of cardiac glutathione with DEM before ischemia may further limit the availability of sulfhydryl groups, which appear necessary for mitochondrial transport and metabolism of fatty acids on reperfusion.36,38 While oxidive stress seems the most likely possibility for effects observed in glutathione-depleted hearts, it is possible that the reduction in glutathionedeprived myocytes of an important source of glycine. Glycine is involved in the detoxification of acyl-CoA, which accumulates during myocardial ischemia.39 Acyl-CoA is an amphipathic molecule that has detergent properties and can inhibit mitochondrial adenine nucleotide translocase.40 It is uncertain whether this mechanism would be relevant in the absence of a source of free fatty acids for oxidative metabolism.
As shown by our washout experiments, the increase in measured cardiac glutathione after perfusion with 2 mM glutathione is almost completely reversed. Tsan and colleagues41 have recently observed that exogenous glutathione increases levels in bovine pulmonary artery endothelial cells and provides additional cytoprotection. In those experiments, glutathione levels were reported after 2 hours of incubation before peroxide exposure. In addition, Tsan et al's results indicate that enhanced levels resulted from breakdown at the cell surface and internal resynthesis. The relatively short exposure, the complex uptake process, and differences in species and vascular bed leave the question of uptake in our experiments open to speculation. In addition, it is unlikely that uptake would account for beneficial effects observed after so brief an exposure. Our experiments do not exclude the possibility that some glutathione may be either adherent to endothelium or retained in heart tissue, but increases in tissue glutathione were not significant in our experiments, an observation that must be interpreted cautiously because of the few washout experiments.
Despite its presumed extracellular locus, infused glutathione effectively reversed changes in function and compliance observed in glutathione-depleted hearts after ischemia and reperfusion. This is consistent with studies showing beneficial effects of superoxide dismutase and catalase administered at the time of reperfusion and further supports the concept that active oxygen species generated within cells promote injury at remote sites by traversing the extracellular environment.282942
